During peripheral infection, excessive production of pro-inflammatory cytokines in the aged brain from primed microglia induces exaggerated behavioral pathologies. While the pro-inflammatory cytokine IL-6 increases in the brain with age, its role in microglia priming is not known. This study examined the functional role of IL-6 signaling on microglia priming. Our hypothesis is that IL-6 signaling mediates primed states of microglia in the aged. An initial study assessed age-related alteration in IL-6 signaling molecules; sIL-6R and sgp130 were measured in cerebrospinal fluid of young and aged wild-type animals. Subsequent studies of isolated microglia from C57BL6/J (IL-6 +/+ ) and IL-6 knock-out (IL-6 −/− ) mice showed significantly less MHC-II expression in aged IL-6 −/− compared to IL-6 +/+ counterparts. Additionally, adult and aged IL-6 +/+ and IL-6 −/− animals were administered lipopolysaccharide (LPS) to simulate a peripheral infection; sickness behaviors and hippocampal cytokine gene expression were measured over a 24 h period. Aged IL-6 −/− animals were resilient to LPSinduced sickness behaviors and recovered more quickly than IL-6 +/+ animals. The age-associated baseline increase of IL-1β gene expression was ablated in aged IL-6 −/− mice, suggesting IL-6 is a key driver of cytokine activity from primed microglia in the aged brain. We employed in vitro studies to understand molecular mechanisms in priming factors. MHC-II and pro-inflammatory gene expression (IL-1β, IL-10, IL-6) were measured after treating BV.2 microglia with sIL-6R and IL-6 or IL-6 alone. sIL-6R enhanced expression of both pro-inflammatory genes and MHC-II. Taken together, these data suggest IL-6 expression throughout life is involved in microglia priming and increased amounts of IL-6 following peripheral LPS challenge are involved in exaggerated sickness behaviors in the aged.
During peripheral infection, excessive production of pro-inflammatory cytokines in the aged brain from primed microglia induces exaggerated behavioral pathologies. While the pro-inflammatory cytokine IL-6 increases in the brain with age, its role in microglia priming is not known. This study examined the functional role of IL-6 signaling on microglia priming. Our hypothesis is that IL-6 signaling mediates primed states of microglia in the aged. An initial study assessed age-related alteration in IL-6 signaling molecules; sIL-6R and sgp130 were measured in cerebrospinal fluid of young and aged wild-type animals. Subsequent studies of isolated microglia from C57BL6/J (IL-6 +/+ ) and IL-6 knock-out (IL-6 −/− ) mice showed significantly less MHC-II expression in aged IL-6 −/− compared to IL-6 +/+ counterparts. Additionally, adult and aged IL-6 +/+ and IL-6 −/− animals were administered lipopolysaccharide (LPS) to simulate a peripheral infection; sickness behaviors and hippocampal cytokine gene expression were measured over a 24 h period. Aged IL-6 −/− animals were resilient to LPSinduced sickness behaviors and recovered more quickly than IL-6 +/+ animals. The age-associated baseline increase of IL-1β gene expression was ablated in aged IL-6 −/− mice, suggesting IL-6 is a key driver of cytokine activity from primed microglia in the aged brain. We employed in vitro studies to understand molecular mechanisms in priming factors. MHC-II and pro-inflammatory gene expression (IL-1β, IL-10, IL-6) were measured after treating BV.2 microglia with sIL-6R and IL-6 or IL-6 alone. sIL-6R enhanced expression of both pro-inflammatory genes and MHC-II. Taken together, these data suggest IL-6 expression throughout life is involved in microglia priming and increased amounts of IL-6 following peripheral LPS challenge are involved in exaggerated sickness behaviors in the aged.
Introduction
Peripheral immune stimulation causes the production of pro-inflammatory cytokines, such as IL-6. The signal for these cytokines is transported to the brain via both neural and humoral pathways, including vagal afferents and direct crossing of the blood-brain barrier (Banks et al., 1994; Maier et al., 2006; Poon et al., 2013; Quan, 2008) . In the brain, microglial cells respond to signals from the periphery by producing pro-inflammatory cytokines, which then target neurons to elicit a sickness behavior response that is adaptive in nature (Robert et al., 2006) . Microglia appear to be the main cell in the brain that express the IL-6 receptor and potently secrete IL-6 during peripheral immune stimulation (Burton et al., 2013) . IL-6 knockout (IL-6 −/− ) mice have shown an overall decrease in the number of activated brain macrophages associated with cortical lesions, suggesting a role for IL-6 in the orchestration of central nervous system inflammation (Penkowa et al., 1999) . IL-6 in the central nervous system is also implicated in a myriad of behavioral pathways, including but not limited to neurodegeneration, astrocytosis, and changes in c-fos expression (Banks et al., 1994; Campbell et al., 1993; Vallières et al., 1997) . In the brain of adult mice, IL-6 plays a pivotal role in mediating lipopolysaccharide (LPS)-induced sickness behaviors (Burton et al., 2011) as well as cognitive deficits (Sparkman et al., 2006; Wei et al., 2015) . Although it is known that aged mice experience exaggerated sickness behaviors (Godbout et al., 2005; Kelley et al., 2013) , it is yet unclear if IL-6 contributes to these behaviors. In addition to the classical IL-6 pathway, where IL-6 binds its receptor on the cell membrane, there is an IL-6 trans-signaling pathway.
